Coherus Oncology, Inc. - Common Stock (CHRS)

CUSIP: 19249H103

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
-3,713,331
Put/Call ratio
41%
SEC-reported price per share
$1.64
Number of holders
110
Value change
-$2,969,339
Number of buys
54
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
154,050,897

Security key

19249H103

Report period

Q3 2025

Institutions

110

Top holders

10

Ownership snapshot

Top reported holders of CHRS - Coherus Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bering Partners II, L.P.
Disclosed value leader
Bering Partners II, L.P.
Comparable rows
15/15
Latest evidence
05 Sep 2025
13D/G 13F Lead comparable stake: 6.5% 13D/G row: Bering Partners II, L.P. Showing 1-6 of 15 holder rows.

Quick read

Bering Partners II, L.P. leads the comparable SEC ownership view at 6.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bering Partners II, L.P.'s linked filing trail.
Comparable ownership Top 5
Bering Partners II, L.P. 6.5%
Rubric Capital Management LP 4.6%
BlackRock, Inc. 7%
VANGUARD GROUP INC 6.9%
TANG CAPITAL MANAGEMENT LLC 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bering Partners II, L.P.
13D/G
Evgeny Zaytsev ("Zaytsev")
6.5%
$12,468,441
7,602,708 shares
$0 05 Sep 2025
Rubric Capital Management LP
13D/G 13F
Company
4.6%
$5,258,754
5,258,754 shares
$0 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
7%
$7,853,949
10,739,710 shares
30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
6.9%
$7,727,047
10,570,515 shares
30 Jun 2025
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
3.3%
$3,727,701
5,097,362 shares
30 Jun 2025
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
13F
2%
$2,174,926
3,036,076 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
110
Shares
51,511,878
Rows available
110
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
109
Q3 2025 holders
110
Holder diff
1
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .